Merck
CN
Search Within
文件类型

2004-14-0

应用筛选条件
关键词:'2004-14-0'
显示 1-30 共 446 条结果 关于 "2004-14-0" 范围 技术文档
Steritest™ Syringe Support User Guide - CHINESE
确保管子被正确置于管子锁 定系统中。 注射器支架已被激活(画面左 上方显示有蓝色注射器图标), 但阀门被卡在闭合位置。图标 中的数字为 “0”。 联系技术服务部。 当阀门是关闭时(画面左上方 显示有蓝色注射器图标,而且 里面有数字 “0”),液体流过 自动阀管锁定系统之后的硅 胶管。 管子未置于管子锁定系统中, 或者放置位置不正确。 确保管子被正确置于管子锁 定系统中
Data sheet - HTS139M
Radioligand binding assay and GTPγS binding. 0 1 2 3 4 5 0 10000 20000 30000 40000 50000 60000 TB NSB SB [125I] Somatostatin 14 (nM) [1 25 I] So
CHEMISCREENTM MEMBRANE PREPARATION RECOMBINANT HUMAN SST3 SOMATOSTATIN RECEPTOR
Radioligand binding assay 0.0 0.5 1.0 1.5 2.0 2.5 0 5000 10000 15000 20000 25000 TB NSB SB [125I]-somatostatin 14 (nM) [1 25 I] -s o m to st at in 1 4
Data Sheet - MAB1637
Stem Cells Dev. 14(4): 354-366. Walczak, P. et al. (2005). Instant MR labeling of stem cells using magnetoelectroporation. Magn. Reson. Med. 54(4): 769-774. Fernandez, M et al. (2004). Thyroid hormone
CHEMISCREEN™ MEMBRANE PREPARATION HUMAN RECOMBINANT 5-HT6 SEROTONIN RECEPTOR
Fax: +1 (951) 676-9209 • Europe +44 (0) 23 8026 2233 Australia +61 3 9839 2000 www.millipore.com 04/14/08/HTS111M/ML -13 -12 -11 -10 -9 -8 -7 -6 -5 -4 0 2000 4000 6000
SeQuant.Poster.HPLC_2008.HILIC_in_Clinical_Applications
828 (2005) 14-20 10. Takegawa Y et al.; J. Chrom. A 1113 (2006) 177-181 11. Appelblad, P.; LCGC EU Apr 2003 12. Jonsson, T et al.; LCGC EU May 2004 13. Appelblad, P et al.; LCGC EU Mar 2005 14. Dibowski
Balancing Histone/Protein Acetylation-Gene Regulation and Cancer Therapy
(2002). 4. Scott, R.J. and Spielman, M., Curr. Biol., 14, R201-R203 (2004). 5. Lund, A.H. and van Lohuizen, M., Genes Dev., 18, 2315-2335 (2004). 6. Polevoda, B. and Sherman, F., Genome Biol., 3, reviews
Analysis of Antibiotic Sulfa Drugs Using Ascentis C18
63-74-1, S9251, sulfacetamide, 144-80-9, S8627, sulfadiazine, 68-35-9, S8626, sulfathiazole, 72-14-0, S9876, sulfamerazine, 127-79-7, S8876, sulfamethizole, 144-82-1, S5632, 581324-U Conditions column
Precision Membrane Preparation Recombinant hERG Potassium Ion Channel
Dofetilide 5.8 ± 2.4 28 ± 6 ND ND 15.3 ± 2.5 E-4031 6.1 ± 0.8 58 ± 5 115 ± 0.02 144 ± 44 14 Pimozide 18.8 ± 2.3 14 ± 4 ND ND 18
Anti-NeuN, clone A60 - Data Sheet
Moreno-Lopez, B. et al., J. Neuroscience (2004) 24:85-95. 43) Harry, G.J., et al., Neurotoxicity Research (2004) 5:623-628. 44) Runyan, J. D., et al., J. Neuroscience (2004) 24:1288-1295. 45) Romera, C.
PRECISIONTM MEMBRANE PREPARATION RECOMBINANT hERG POTASSIUM ION CHANNEL
Dofetilide 5.8 ± 2.4 28 ± 6 ND ND 15.3 ± 2.5 E-4031 6.1 ± 0.8 58 ± 5 115 ± 0.02 144 ± 44 14 Pimozide 18.8 ± 2.3 14 ± 4 ND ND 18
Data Sheet 1.46165.0020 Tryptose Sulfite Cycloserine (TSC) Agar
DIN EN ISO 7937:2004-11: Microbiology of food and animal feeding stuffs - Horizontal method for the enumeration of Clostridium perfringens - Colony-count technique (ISO 7937:2004); German version
Kinase Peptide Microarray - Random Tyrosine Library
6.2.E Remove incubation chamber 14 6.2.F Wash 14 6.2.G Prepare the slide for the antibody incubation 14 6.2.H Incubate with antibody 14 6.2.I Final washing steps 14 6.2.J Scan the peptide microarray
Kinase Peptide Microarray - Random Threonine Library
Remove incubation chamber 14 6.2.F Wash 14 6.2.G Prepare the slide for the antibody incubation 14 6.2.H Incubate with antibody 14 8 6.2.I Final washing steps 14
Montage BAC 96 Miniprep Kit
.................................... 14 References ............................................................................... 17 P36392A_cover.pmd 5/24/2004, 10:53 AM3 Ordering Information
Adipolysis Assay Kit
role (Rydén et al., 2002; Rydén et al., 2004). In addition, extracellular glucose is required for the TNF-α-mediated adipocyte lipolysis (Green, et al., 2004). Glycerol generated by triglyceride breakdown
Analysis of Estrone B-Estradiol a-Estradiol and Estriol Using Ascentis C18
H H H OH HO H H H 4 Ascentis is a trademark of Sigma-Aldrich Co. 0 2 4 6 8 10 12 14 Min
Analysis of Cannabinoids Using Ascentis C18
IDs 1. Cannabidiol 2. Cannabinol 3. ∆-9-tetrahydrocannabinol G002326 ©2004 Sigma-Aldrich Co. T003083 0 2 4 6 8 10 12 14 Min 1 2 3 OH OH O OH O HO H
Poster: Purification of Peptides from Serum and Cell Lysates for Mass Spectrometry, ASMS, 2004
Hill Drive, Danvers, MA, USA, 2Proteome Systems, Ltd, 14 Gill Street, Woburn, MA, USA 700 1219 1738 2257 2776 3295 Mass (m/z) 0 9.3E+3 0 10 20 30 40 50
CHEMISCREENTM MEMBRANE PREPARATION RECOMBINANT HUMAN ChemR23 CHEMOATTRACTANT RECEPTOR
APPLICATIONS: GTPγS Binding and Radioligand Binding Assay. -14 -13 -12 -11 -10 -9 -8 -7 -6 -5 0 2000 4000 6000 8000 10000 ChemR23 WT [Chemerin] LogM
Biologics 31.1
(Cat. No. 662005). Purity: ≥95% by HPLC. M.W. 374.5. Ref.: Wityak, J., et al. 2004. Bioorg. Med. Chem. Lett. 14, 1483. Rho-Kinase Inhibitor II [N-(4-Pyridyl)-N’-(2,4,6-trichlorophenyl)urea] A potent
Calbiochem Biologics 31.1
(Cat. No. 662005). Purity: ≥95% by HPLC. M.W. 374.5. Ref.: Wityak, J., et al. 2004. Bioorg. Med. Chem. Lett. 14, 1483. Rho-Kinase Inhibitor II [N-(4-Pyridyl)-N’-(2,4,6-trichlorophenyl)urea] A potent
Data Sheet - AB2051
Europe +44 (0) 23 8026 2233 Australia +61 3 9839 2000 • Germany +49-6192-207300 • ISO Registered worldwide www.chemicon.com • custserv@chemicon.com • techserv@chemicon.com 01/14/2004/AB2051/TB
Calbiochem Biologics 30.2
of 31 other kinases. Purity: ≥98% by TLC. M.W. 224.3. Ref.: Baxter, A., et al. 2004. Bioorg. Med. Chem. Lett. 14, 2817; Kishore, N., et al. 2003. J. Biol. Chem. 278, 32861. IKK Inhibitor III
Nitrotyrosine Assay Kit
then dropped at 10 mM.
hTRPV1-HEK293 Recombinant Cell Line
35 41 45 0 1 2 3 4 Passage 0 20 40 60 80 100 M e a n C u rr e n t A m
Data Sheet - M1445
is derived from the hybridoma MTA30 2G10/3 produced by the fusion of mouse myeloma cells (Sp2/0 Ag.14 cells) and splenocytes from BALB/c mice immunized with Mus81 protein. The isotype is determined
Real-time Quantitative RepresentationMeasurement of Eighty Loci Using GenomePlex Whole Genome Amplification
linkage panel. Genome Research, 14, 901-907 (2004). 3. Gribble, S. et al., Chromosome paints from single copies of chromosomes. Chromosome Research 12, 143-151 (2004). GenomePlex and OmniPlex are
Experience Biopharm - Course Offerings 2014
Applied Sciences, Mannheim, Germany • 2004-Present, Director of the Steinbeis Transfer Centre “Technical Consulting“ • Since 2004 Head of the Institute for
1/15